Related Articles
Circulating tumor DNA dynamics and response to immunotherapy in colorectal cancer
Identification of circulating tumor DNA using a targeted 545‑gene next generation sequencing panel in patients with gastric cancer
Assessment of basal-like breast cancer by circulating tumor DNA analysis
Detecting liquid remnants of solid tumors treated with curative intent: Circulating tumor DNA as a biomarker of minimal residual disease (Review)
Variant allele frequency changes in TP53 predict pembrolizumab response in patients with metastatic urothelial carcinoma